Population Health Management - AHIP · health care as a driver of Population Health Management ......
34
1 This whitepaper addresses value-based health care as a driver of Population Health Management (PHM), the integral role of pharmacy-based Population Health Management, and strategies for optimizing patient care capacity to improve health outcomes and lower costs of patient care. Market Landscape While healthcare costs per capita are higher in the U.S. than anywhere else in the world, the nation’s health outcomes are far from the best. 1 According to the National Academy of Medicine, waste accounts for nearly 30% of the total $3.2T U.S healthcare budget. 2 Meanwhile, costs are increasing at an exorbitant rate, fast approaching 20% of the U.S. GDP. 3 Quality improvement and cost reduction have become a national imperative. 4 The nation’s healthcare industry is under tremendous pressure to reduce waste at all levels and improve quality of care and health outcomes. Escalating costs are shifting our healthcare economy from traditional fee-for-service to value-based payment models. 5 Rather than simply caring for individual patients actively seeking care, healthcare professionals must be equipped to care proactively for entire populations, and receive compensation for the outcomes they achieve, rather than the services they deliver. Success within this new value-based landscape of Population Health Management (PHM) requires new partner alignment, innovation in data harnessing, and value- based prioritization in the allocation of scarce healthcare resources. 6 . Our future healthcare economy will require healthcare professionals to care proactively for entire populations and be compensated based upon outcomes achieved rather than services delivered. Omnicell, Inc. | Population Health Management: Optimizing Pharmacy’s Capacity for Value-Based Patient Care WHITEPAPER Unnecessary Services $210 Billion Excessive Administrative Costs $190 Billion Prices That Are Too High $105 Billion Inefficiently Delivered Services $130 Billion Fraud $75 Billion Missed Prevention Opportunities $55 Billion
Transcript of Population Health Management - AHIP · health care as a driver of Population Health Management ......
1
This whitepaper addresses value-based health care as a driver of Population Health Management (PHM), the integral role of pharmacy-based Population Health Management, and strategies for optimizing patient care capacity to improve health outcomes and lower costs of patient care.
Market Landscape
While healthcare costs per capita are higher in the U.S. than anywhere else in the world, the nation’s health outcomes are far from the best.1 According to the National Academy of Medicine, waste accounts for nearly 30% of the total $3.2T U.S healthcare budget.2 Meanwhile, costs are increasing at an exorbitant rate, fast approaching 20% of the U.S. GDP.3 Quality improvement and cost reduction have become a national imperative.4 The nation’s healthcare industry is under tremendous pressure to reduce waste at all levels and improve quality of care and health outcomes.
Escalating costs are shifting our healthcare economy from traditional fee-for-service to value-based payment models.5 Rather than simply caring for individual patients actively seeking care, healthcare professionals must be equipped to care proactively for entire populations, and receive compensation for the outcomes they achieve, rather than the services they deliver. Success within this new value-based landscape of Population Health Management (PHM) requires new partner alignment, innovation in data harnessing, and value-based prioritization in the allocation of scarce healthcare resources.6.
Our future healthcare economy will require healthcare professionals
to care proactively for entire populations and be compensated based upon outcomes achieved rather than services delivered.
Omnicell, Inc. |
Population Health Management:Optimizing Pharmacy’s Capacity for Value-Based Patient Care
WHITEPAPER
Unnecessary Services$210 Billion
Excessive Administrative Costs
$190 Billion
Prices That Are Too High$105 Billion
Inefficiently Delivered Services
$130 Billion
Fraud$75 Billion
Missed Prevention Opportunities
$55 Billion
Population Health
Management is the
primary discipline
influencing
healthcare delivery
transformation.
.
.
David Katz, MD
Director, Yale University Prevention Research Center
Omnicell’s Patient Management Access Portal (PMAP)
Omnicell’s Time My Meds® Medication Synchronization (Med Sync)
Appointment-Based Model (ABM)
Medications account for
$310B
in spending in U.S.
today; optimizing their
use through improved
adherence alone could
save
$290B
Institute for Healthcare Improvement, 2015
≥
≥
REFERENCES1. http://wunc.org/post/one-north-carolinas-top-docs-busts-3-myths-about-healthcare#stream/0
2. http://resources.iom.edu/widgets/vsrt/healthcare-waste.html
3. Health Affairs, “National Health Expenditure Projections, 2014–24: Spending Growth Faster Than Recent Trends”
4. http://www.aacp.org/resources/research/pharmacyworkforcecenter/Documents/ExecutiveSummaryFromTheNationalPharmacistWorkforceStudy2014.pdf
5. http://avalere.com/expertise/life-sciences/insights/exploring-pharmacists-role-in-a-changing-healthcare-environment
6. http://avalere.com/expertise/life-sciences/insights/exploring-pharmacists-role-in-a-changing-healthcare-environment
7. Donald M. Berwick, Thomas W. Nolan, and John Whittington, “The Triple Aim: Care, Health, and Cost,” Health Affairs 27, no. 3 (2008): 759-769.
8. http://healthaffairs.org/blog/2015/04/06/what-are-we-talking-about-when-we-talk-about-population-health/
9. http://www.hhs.gov/about/news/2015/01/26/better-smarter-healthier-in-historic-announcement-hhs-sets-clear-goals-and-timeline-for-shifting-medicare-reimbursements-from-volume-to-value.html; accessed 9/19/16
10. Definitions of Population Health, Applications, and Capabilities from: Barclays Capital Inc., U.S. Healthcare Distribution & Technology: HCIT: What we talk about When We Talk About Population Health, March, 2014
11. http://www.hhs.gov/about/news/2015/01/26/better-smarter-healthier-in-historic-announcement-hhs-sets-clear-goals-and-timeline-for-shifting-medicare-reimbursements-from-volume-to-value.html
12. http://ihealthtran.com/pdf/PHMReport.pdf
13. Suzannea Felt-Lisk and Tricia Higgins, “Exploring the Promise of Population Health Management Programs to Improve Health,” Mathematica Policy Research Issue Brief, August 2011, accessed at http://www.mathematica-mpr.com/publications/pdfs/ health/PHM_brief.pdf
14. Source: Population Health Management, Institute for Health Technology Transformation
15. Feygin D, Ross D. Population Health Management An Unstoppable Transformation
16. AHRQ, “Practice-Based Population Health,” 1
17. Reference: Ian Duncan, Healthcare Risk Adjustment and Predictive Modeling (Winstead, CT: ACTEX Publications, 2011).
18. AHRQ, “Practice-Based Population Health,” 15-16
19. David Margolius and Thomas Bodenheimer, “Transforming Primary Care: From Past Practice to Practice of the Future.” Health Affairs, 29, no. 5 (2010):779-784
20. Hodach, “The Promise of Population Health Management”
21. Hodach, ‘ACPs Will Need Automation Tools to Do Population Health Management,” National Healthcare Reform Magazine. October 19, 2010, accessed at http://www.healthcarereformmagazine.com/article/acos-will-need-automation-tools-to-do-population-health-management.html
22. Anand K. Parekh, “Winning Their Trust.” N Engl J Med 2011; 364:e51June 16, 2011
23. http://m.healthaffairs.org/blog/2015/04/06/what-are-we-talking-about-when-we-talk-about-population-health/
24. David Margolius and Thomas Bodenheimer, “Transforming Primary Care: From Past Practice to Practice of the Future.” Health Affairs, 29, no. 5 (2010):779-784.
25. AHRQ, “Practice-Based Population Health,” 21-22.
26. AHRQ, “Practice-Based Population Health,” 21-28.
27. http://www.fightchronicdisease.org/sites/fightchronicdisease.org/files/docs/GrowingCrisisofChronicDiseaseintheUSfactsheet_81009.pdf
28. Source: World Congress, Erin Neal PharmD, Vanderbilt Health
29. http://www.aacp.org/resources/research/pharmacyworkforcecenter/Documents/ExecutiveSummaryFromTheNationalPharmacistWorkforceStudy2014.pdf
30. Timothy Wilt, M.D., M.P.H., David Katz, M.D., director, Yale University Prevention Research Center, April 25, 2016, Annals of Internal Medicine, published online
31. http://www.nacds.org/pdfs/pr/2012/3_28_SASC_TRICARE_comments.pdf
32. http://www.hhs.gov/about/news/2015/01/26/better-smarter-healthier-in-historic-announcement-hhs-sets-clear-goals-and-timeline-for-shifting-medicare-reimbursements-from-volume-to-value.html; accessed 9/19/16
33. Kraemer DF, Kradjan WA, Bianco TM, Low JA. A randomized study to assess the impact of pharmacist counseling of employer-based health plan beneficiaries with diabetes: the EMPOWER study. J Pharm Pract. 2012;25(2):169-79. doi: 10.1177/0897190011418513.
34. Patwardhan PD, Amin ME, Chewning BA. Intervention research to enhance community pharmacists’ cognitive services: a systematic review. Res Social Adm Pharm. 2014;10(3);475-93. doi: 10.1016/j.sapharm.2013.07.005.
35. Iuga AO, McGuire MJ. Risk Manag Healthc Policy. 2014; 7: 35–44. Published online 2014 Feb 20. doi: 10.2147/RMHP.S19801
36. http://healthitanalytics.com/
37. http://www.beckershospitalreview.com/quality/study-medication-reconciliation-programs-halve-hospital-readmissions-6.html
38. Relling MV, Evans WE. Pharmacogenomics in the clinic. Nature. 2015;526(7573):343-50.
39. http://www.pharmacypracticenews.com/ViewArticle.aspx?d=Clinical&d_id=50&i=March+2015&i_id=1155&a_id=30831
40. Relling MV, Evans WE. Pharmacogenomics in the clinic. Nature. 2015;526(7573):343-50.
41. http://www.cdc.gov/aging/pdf/cps-clinical-preventive-services.pdf
42. Point of Care testing emerging markets.Jan/Feb 2015.AmPharmAssn
43. http://www.knowledgedriven.com/articles/pharmacies/cmr-completion-measure-highlights-2016-star-ratings-update.aspx?hootPostID=ee9667e6a8c145aad7f38bbdb5ae54aa#.V31oCrnD-Uk
44. Thomas Pearson, “The Prevention of Cardiovascular Disease: Have We Really Made Progress?” Health Affairs 26, no. 1 (2007): 49– 60.
45. Anand K. Parekh, “Winning Their Trust.” N Engl J Med 2011; 364:e51June 16, 2011.
46. ISMP Medication Safety Alert. 2012 Institute for Safe Medication Practices. Retrieved from http://www.ismp.org/newsletters/acutecare/issues/20121115.pdf
47. http://www.cdc.gov/nchs/data/databriefs/db76.htm; Accessed March 22, 2016.
48. Cantrell CR, Eaddy MT, Shah MB, Regan TS, Sokol MC. Methods for evaluating patient adherence to antidepressant therapy: A real-world comparison of adherence and economic outcomes. Med Care.2006;44(4):300–303.
49. ISMP Medication Safety Alert. 2012 Institute for Safe Medication Practices. Retrieved from http://www.ismp.org/newsletters/acutecare/issues/20121115.pdf
50. American Diabetes Association, 2012
51. Balkrishnan R, Rajagopalan R, Camacho FT, et al. Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: a longitudinal cohort study. Clin Ther. 2003 Nov;25(11):2958–2971. [PubMed]
52. Egede LE, Gebregziabher M, Dismuke CE, et al. Medication nonadherence in diabetes: Longitudinal effects on costs and potential cost savings from improvement. Diabetes Care. 2012;35(12):2533–2539. [PMC free article] [PubMed]
53. https://www.tn.gov/aging/topic/fall-prevention#sthash.a2vPYszB.dpuf
54. Alexander BH, Rivara FP, Wolf ME. The cost and frequency of hospitalization for fall–related injuries in older adults. American Journal of Public Health 1992;82(7):1020–3.
55. Centers for Disease Control and Prevention, National Center for Injury Prevention and Control. Web–based Injury Statistics Query and Reporting System (WISQARS) [online]. Accessed August 15, 2013.
56. Retrieved from http://www.eldercareteam.com/public/400.cfm
57. http://kff.org/other/state-indicator/admissions-by-ownership/
58. Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, Ezekowitz MD, et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation. 2011;123(8):933–44
59. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, et al. Heart disease and stroke statistics—2013 update: a report from the American Heart Association. Circulation. 2013;127:e6–e245.
60. http://www.emoryhealthcare.org/heart-failure/learn-about-heart-failure/statistics.html
Omnicell and the Omnicell design mark are registered trademarks and Time My Meds is a trademark of Omnicell, Inc. in the United States and internationally. All other trademarks and names are the property of their respective owners.©2017 All rights reserved. Rev. A 06/17
61. https://innovation.cms.gov/files/reports/mtm-interim-report-01-2013.pdf
62. http://www.empr.com/news/2016-recommended-immunization-schedule-for-adults-whats-changed/article/471432/2/ Accessed February 21, 201
63. http://www.guideline.gov/search/search.aspx?term=urinary+incontinence
64. Improving Care Transitions: Optimizing Medication , March 2012, APhA/ASHP
65. Centers for Disease Control and Prevention (CDC). Adult Vaccination Coverage-United States, 2010. MMWR. February 7, 2014 / 63(05);95-102
66. Williams WW, et al; Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep. 2014;63(5):95-102
67. Williams WW, et al; Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep. 2014;63(5):95-102
68. CDC National Immunization Survey, CDC National Health Interview Survey, CDC Behavioral Risk Factor Surveillance System, Minnesota Population Center and State Health Access Data Assistance Center Integrated Health Interview Series
69. CDC National Immunization Survey, CDC National Health Interview Survey, CDC Behavioral Risk Factor Surveillance System, Minnesota Population Center and State Health Access Data Assistance Center Integrated Health Interview Series.
70. COPE Survey, COPD Foundation
71. ISMP Medication Safety Alert. 2012 Institute for Safe Medication Practices. Retrieved from http://www.ismp.org/newsletters/acutecare/issues/20121115.pdf
72. Iuga AO, McGuire MJ. Risk Manag Healthc Policy. 2014; 7: 35–44. Published online 2014 Feb 20. doi: 10.2147/RMHP.S19801
73. Hajjar E, Hanlon JT, Sloane RJ, et al. Unnecessary drug use in frail older people at hospital discharge. J Am Geriatr Soc. 2005;53:1518–1523.
74. Akazawa M, Imai H, Igarashi A, Tsutani K. Potentially inappropriate medication use in elderly Japanese patients. Am J Geriatr Pharmacother. 2010;8:146–160.
75. Bourgeois FT, Shannon MW, Valim C, et al. Adverse drug events in the outpatient setting: an 11-year national analysis. Pharmacoepidemiol Drug Saf. 2010;19:901–10
76. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3864987/
77. http://www.ahdbonline.com/issues/2014/march-2014-volume-7-special-feature-fifth-annual-payers-guide-to-new-fda-approvals/1704-specialty-drugs-top-the-trends-in-the-2014-pipeline
Omnicell believes that pharmacy is the future of healthcare…and it shows.
This Population Health White Paper represents the views of the author, not America’s Health Insurance Plans (AHIP). The publication, distribution or posting of this Population Health White Paper by AHIP does not constitute a guaranty of any product or service by AHIP.
